1. Home
  2. PRAX vs TTEK Comparison

PRAX vs TTEK Comparison

Compare PRAX & TTEK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$325.47

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Tetra Tech Inc.

TTEK

Tetra Tech Inc.

HOLD

Current Price

$36.12

Market Cap

9.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
TTEK
Founded
2015
1966
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Military/Government/Technical
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
9.5B
IPO Year
2020
1995

Fundamental Metrics

Financial Performance
Metric
PRAX
TTEK
Price
$325.47
$36.12
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
$572.13
$44.00
AVG Volume (30 Days)
364.5K
3.5M
Earning Date
05-12-2026
04-29-2026
Dividend Yield
N/A
0.71%
EPS Growth
N/A
N/A
EPS
N/A
0.40
Revenue
N/A
$2,964,148,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6,395.88
$6.53
P/E Ratio
N/A
$91.74
Revenue Growth
N/A
7.66
52 Week Low
$26.70
$27.27
52 Week High
$354.87
$43.14

Technical Indicators

Market Signals
Indicator
PRAX
TTEK
Relative Strength Index (RSI) 53.52 48.78
Support Level $290.36 $34.99
Resistance Level N/A $38.19
Average True Range (ATR) 18.34 1.83
MACD -2.56 -0.11
Stochastic Oscillator 57.24 47.53

Price Performance

Historical Comparison
PRAX
TTEK

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About TTEK Tetra Tech Inc.

Tetra Tech Inc provides consulting and engineering services for environmental, infrastructure, resource management, energy, and international development markets. It specializes in providing water-related services for public and private clients. It designs infrastructure, facilities, and other structures with complex plans and resource management. it has two reportable segments. Its Government Services Group (GSG) segment includes activities with U.S. government clients (federal, state and local) and activities with development agencies world-wide. Commercial/International Services Group (CIG) segment, which derives maximum revenue, includes activities with U.S. commercial clients and international clients other than development agencies.

Share on Social Networks: